Do you know anyone using DxH 900 Hematology Analyzer?

The DxH 900 hematology analyzer enables your high volume laboratory to achieve superb RBC, PLT, and WBC differentials through near-native state cellular characterization. Beckman Coulter Inc., is a danaher corporation company that develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing.

Its features are:

  • Achieve superb RBC, PLT and WBC differentials through near native-state cellular characterization
  • Deliver reliable, reportable WBC differential results on the first run, through VCS 360 technology, DataFusion, and the enhanced Coulter Principle. These core technologies provide high-resolution characterization without altering cell morphology, providing excellent hematological test results;
  • Support critical clinical decisions through advanced PLT analysis. The enhanced Coulter Principle provides a reportable MPV- even for thrombocytopenic patients- while DataFusion leverages inter-module intelligence to enable improved flagging and identification of interferences.
DxH 900 Hematology Analyzer

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Mar 28, 2024 at 3:00am